SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : TGEN - Targeted Genetics Corporation
TGEN 8.230+0.9%Nov 7 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mike McFarland who wrote (257)2/23/2000 2:08:00 AM
From: GlobalMarine of 557
 
Don't forget their SUPER BLOCKBUSTER, Hemophilia A, factor VIII vector. In the CEO interview, Parker explicitly mentioned it, saying that there was appropriate expression, and even more than appropriate expression of over a year in mice. A better approach, chopping the factor VIII gene's superfluous parts so that it fits in an AAV vector, than AVGN's of chopping the gene in two and carrying each separately, though it's very nice to know that it too expresses.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News